ArticleMedicines (Basel, Switzerland)2018

Oral Intake of Royal Jelly Has Protective Effects Against Tyrosine Kinase Inhibitor-Induced Toxicity in Patients with Renal Cell Carcinoma: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Kyohei Araki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.